Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

1 Apr 2022 07:00

RNS Number : 8683G
Lekoil Limited
01 April 2022
 

1 April 2022

 

Lekoil Limited

("LEKOIL" or the "Company")

Corporate Update

LEKOIL (AIM: LEK), the oil and gas exploration and production company with a focus on Nigeria and West Africa, provides the following corporate updates.

Suspension of trading in Company shares

As shareholders will be aware, trading in the Company's Ordinary Shares ("Shares") were suspended with effect from 7.30 a.m. on 1 October 2021. The Company has been advised by its Nominated Adviser that trading in its Shares will remain suspended while it continues to work with its Nominated Advisor on matters that are required for trading in the Shares to be restored and in the event trading cannot be restored in due course, the Company's admission to trading on AIM will be cancelled.

Board remuneration

The Company provides the following update for the current remuneration agreed with the Company's Board of Directors.

· Base compensation, for each Board member, of circa US$40,000 per annum (i.e., US$240,000 per annum for 6 Board members).

· The Company's Interim Executive Chairman is entitled to an additional US$50,000 for his additional work in 2021 and an amount, at the Board's discretion, for his additional work in 2022.

· The Company may elect to pay the compensation in either cash or Shares. At present, the Company has elected to pay all outstanding compensation in Shares but without any issuances of Shares to date.

· Any payment is Shares is to be calculated by reference to a deemed share price of 1.5p (for compensation due for 2021) or the higher of 1.5p and the 30-day VWAP (for compensation due in 2022).

 

Extraordinary General Meeting - 7 April 2022

The Company notes that the extraordinary general meeting to be held on 7 April 2022 will be held at 4.00 p.m. Greenwich Mean Time (GMT)/ 5.00 p.m. British Summer Time (BST). Shareholders who wish to attend should contact info@lekoilplc.com for dial-in details.

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

 

 

For further information, please visit www.lekoilplc.com or contact:

SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)

Jeff Keating / Stuart Gledhill

 

+44 20 3470 0470

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUAOURUOUOOUR
Date   Source Headline
10th Sep 20214:13 pmRNSHolding(s) in Company
10th Sep 202112:47 pmRNSDirector Loan - Update
8th Sep 202112:42 pmRNSCorporate update
2nd Sep 202112:17 pmRNSConvertible Facility Agreement
2nd Sep 20219:05 amRNSSecond Price Monitoring Extn
2nd Sep 20219:00 amRNSPrice Monitoring Extension
2nd Sep 20217:00 amRNSCorporate & Operational Update
1st Sep 20214:40 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20212:05 pmRNSSecond Price Monitoring Extn
1st Sep 20212:00 pmRNSPrice Monitoring Extension
1st Sep 202111:59 amRNSHolding(s) in Company
31st Aug 20214:40 pmRNSSecond Price Monitoring Extn
31st Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 202111:06 amRNSSecond Price Monitoring Extn
10th Aug 202111:00 amRNSPrice Monitoring Extension
5th Jul 20214:40 pmRNSSecond Price Monitoring Extn
5th Jul 20214:35 pmRNSPrice Monitoring Extension
5th Jul 20212:06 pmRNSSecond Price Monitoring Extn
5th Jul 20212:00 pmRNSPrice Monitoring Extension
2nd Jul 20214:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20212:05 pmRNSSecond Price Monitoring Extn
2nd Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jun 20217:00 amRNSChange of website address
21st Jun 20213:30 pmRNSResignation of CFO
18th Jun 202112:53 pmRNSDirectorate Change
17th Jun 20217:00 amRNSDelay in publication of Annual Results for 2020
10th Jun 20217:00 amRNSCorporate Update
3rd Jun 20217:00 amRNSDirectorate Change
17th May 20217:00 amRNSAward of Options
20th Apr 20217:07 amRNSDirectorate Change
15th Apr 20218:15 amRNSDirectorate Change
26th Mar 20217:00 amRNSTrading and operational update
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
10th Mar 20211:45 pmRNSDirector Loan - Update
26th Feb 20217:00 amRNSTR-1: notification of major holdings
24th Feb 20217:00 amRNSRe Cost and Revenue Sharing Agreement for OPL 310
4th Feb 20214:40 pmRNSSecond Price Monitoring Extn
4th Feb 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSJoint Broker Appointment
11th Jan 20217:00 amRNSAppointment of Chairman
8th Jan 202112:28 pmRNSResult of EGM
8th Jan 20217:00 amRNSRE Extraordinary General Meeting
7th Jan 20211:20 pmRNSResponse to Press Speculation
31st Dec 202012:43 pmRNSJoint Broker Resignation
29th Dec 20202:06 pmRNSSecond Price Monitoring Extn
29th Dec 20202:01 pmRNSPrice Monitoring Extension
22nd Dec 20206:05 pmRNSAppointment of Nominated Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.